Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-24-000074
Filing Date
2024-01-29
Accepted
2024-01-29 16:55:16
Documents
2
Group Members
CARL L. GORDONEREZ CHIMOVITSORBIMED ADVISORS ISRAEL II LTDORBIMED CAPITAL GP V LLCORBIMED CAPITAL GP VI LLCORBIMED GENESIS GP LLCORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIPORBIMED ISRAEL GP II, L.P.ORBIMED ISRAEL GP LTD.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 ss2965118_sc13da-adicet.htm SC 13D/A 246955
2 JOINT FILING AGREEMENT ss2965118_ex9901.htm EX-99.1 14878
  Complete submission text file 0000947871-24-000074.txt   263868
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Subject) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90283 | Film No.: 24574413
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)